Day3 Posted - 5 hours ago

$VIRX They get given a delisting notice and the option to appeal (which they will). Stock remains listed until outcome of appeal. They will have to evidence how they can regain compliance with 1. $1 bid rule - only way is to call a vote for and implement a reverse split. 2. $2.5m shareholder equity rule - options are investment or offering. If they can evidence both, they will get an extension to actually carry out the above. Neither of the above is good for the stock short term.

Shine1313 Posted - 6 hours ago

$VIRX pop

RB818 Posted - 6 hours ago

$VIRX

Eurydice Posted - 7 hours ago

$VIRX 11/25/24 is near. What is the appeal process?

taneraydar Posted - 11 hours ago

$VIRX doubled my position

SupraFastAlerts Posted - 1 day ago

$VIRX Flying under the radar, swinging 0.14-0.15s. Period of low volume/volatility. Run due soon, something significant 0.30s+: https://www.viracta.com/pipeline/ $XBI $ $TNXP $QQQ $XCUR

SupraFastAlerts Posted - 1 day ago

$VIRX Bought 0.14-15s for 0.30s+

Shine1313 Posted - 1 day ago

$VIRX what is the drug that fda may approve?

bubblegumkid Posted - 2 days ago

$VIRX if this gets fda approval or a buyout… what’s everyone thinking 💭

avatar16 Posted - 2 days ago

$VIRX buyout incoming

NVDAMillionaire Posted - 2 days ago

$VIRX Viracta Therapeutics (VIRX): Navigating the Complexities of Virus-Associated Cancers https://beyondspx.com/article/viracta-therapeutics-inc-nasdaq-virx-a-promising-precision-oncology-company-focused-on-virus-associated-cancers

taneraydar Posted - 3 days ago

$VIRX i am in

Eurydice Posted - 6 days ago

$VIRX what a joke Josh Schimmer?

Eurydice Posted - 6 days ago

$VIRX 🖕

Day3 Posted - 6 days ago

$VIRX Now, their biggest institutional holder BVF has liquidated their entire position. Just gets worse... https://www.sec.gov/Archives/edgar/data/918923/000092189524002727/sc13ga1007422virx_11142024.htm

anachartanalyst Posted - 1 week ago

$VIRX https://anachart.com/wp-content/uploads/ana_temp/1731607354_soc-img.jpg

CapitalistKid Posted - 1 week ago

$VIRX

Day3 Posted - 1 week ago

$VIRX As confirmed in their quarterly results PR and 10-Q report, they will run out of cash end of Q1 2025 and are now out of compliance with $2.5m min SH equity (-$6.7m) as well as $1 min bid price. As they won't be eligible for an extension due to the above, they will be issued a delisting notice on or after 25th Novemeber and will have to appeal at a panel hearing to stay listed. Then comes the reverse split, followed by bankruptcy in early 2025 due to $17m loan which the lender will force repayment of. Absolute s**t show and such a shame, as they were onto something with their drug platform. Source: https://www.sec.gov/Archives/edgar/data/1061027/000095017024126385/virx-20240930.htm

CapitalistKid Posted - 1 week ago

$VIRX Very

bubblegumkid Posted - 1 week ago

$VIRX It sounds like they’re trying to get things in place for FDA approval by the first half of 2025….. based on their recent statement. I guess we’ll have to wait some more 🥱

PenkeTrading Posted - 1 week ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Viracta Therapeutics Inc. Is that bullish or bearish? $VIRX #Viracta #RsiOversold #NASDAQ

schwven Posted - 1 week ago

$VIRX come to papa i am waiting 0.15~~

nahhhhh Posted - 1 week ago

$VIRX where is the 10Q/earnings?

Day3 Posted - 1 week ago

$VIRX Almost the end for these guys, sadly. Next steps as follows: ER will show them out of compliance with $2.5m min SH equity value This means they will be issued a delisting notice + appeal at a hearing If Nasdaq agree, company will be forced to call a vote to implement a reverse split before Year End to comply with $1 min bid Their cash will run out by end of Q1 2025 and they have no way of raising the required cash to either continue operating or to comply with Nasdaq They will have no choice but to file for bankruptcy given their $19m in debt.

bubblegumkid Posted - 1 week ago

$VIRX I’m hearing the possibility of a buyout however this is from people on other forums. So don’t take it as gospel. Not quite sure what this means for the stock price though. I guess we’ll know after earning today 🙏🏼

StockWriter69 Posted - 1 week ago

$VIRX any expectations on earnings?

taneraydar Posted - 1 week ago

$VIRX on watchlist now

Eurydice Posted - 1 week ago

$VIRX For 4 years, I have checked every morning. It has been nothing but misery. I wish I could go back. It has ruined my ability to enjoy life. my own fault.

TheFedSucks Posted - 2 weeks ago

$VIRX Still to come this year. Viracta plans to deliver on the following milestones: The recommended Phase 2 dose in patients with advanced EBV+ solid tumors is expected to be determined in the second half of 2024. Report additional data from the expansion phase of the NAVAL-1 trial in second-line EBV+ PTCL patients in the fourth quarter of 2024.

Hiimbill Posted - 2 weeks ago

$VIRX buyout in after hours PR … you heard it here first!